BDSX Stock: Unveiling the Company’s Financial Health
BDSX Stock: Unveiling the Company’s Financial Health Biodesix Inc. (NASDAQ: BDSX/BDSX Stock) has built a solid foundation in the biotech world, with a revenue increase that signals positive momentum. In fiscal year 2024, Biodesix posted impressive earnings of $71.3 million, marking a 45% rise from the previous year. This robust performance, paired with gross margins…